• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上皮性卵巢癌中转化生长因子 1、血管内皮生长因子和白细胞介素 10 的过表达及其免疫抑制功能。

Overexpression and immunosuppressive functions of transforming growth factor 1, vascular endothelial growth factor and interleukin-10 in epithelial ovarian cancer.

机构信息

Gynecology Oncology Center, Peking University People's Hospital, Beijing 100044, China.

出版信息

Chin J Cancer Res. 2012 Jun;24(2):130-7. doi: 10.1007/s11670-012-0130-y.

DOI:10.1007/s11670-012-0130-y
PMID:23359769
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3555263/
Abstract

OBJECTIVE

Transforming growth factor-1 (TGF-β1), vascular endothelial growth factor (VEGF), and interleukin-10 (IL-10) may be critical cytokines in the microenvironment of a tumor, playing roles in immune suppression. This study was conducted to elucidate the roles and immunosuppressive functions of these cytokines in epithelial ovarian cancer (EOC).

METHODS

The expression levels of TGF-β1, VEGF and IL-10 in malignant tissue were evaluated by immune- histochemistry and compared with corresponding borderline, benign, and tumor-free tissues. Moreover, relationships among the levels of these cytokines and correlations between expression and the prognosis of EOC were analyzed by Pearson rank correlations and multi-factor Logistic regression. The roles of TGF-β1, VEGF, and IL-10 in the immunosuppressive microenvironment of ovarian cancer were studied through dendritic cell (DC) maturation and CD4+CD25+FoxP3+ Treg generation in vitro experiments.

RESULTS

TGF-β1, VEGF, and IL-10 were expressed in 100%, 74.69%, and 54.96% of EOC patients, respectively. TGF-β1 was an independent prognostic factor for EOC. IL-10 was significantly co-expressed with VEGF. In vitro, VEGF and TGF-β1 strongly interfered with DC maturation and consequently led to immature DCs, which secreted high levels of IL-10 that accumulated around the tumor site. TGF-β1 and IL-10 induced Treg generation without antigen presentation in DCs.

CONCLUSIONS

TGF-β1, VEGF and IL-10 play important roles in EOC and can lead to frequent immune evasion events.

摘要

目的

转化生长因子-β1(TGF-β1)、血管内皮生长因子(VEGF)和白细胞介素-10(IL-10)可能是肿瘤微环境中的关键细胞因子,在免疫抑制中发挥作用。本研究旨在阐明这些细胞因子在卵巢上皮性癌(EOC)中的作用及其免疫抑制功能。

方法

采用免疫组织化学法检测恶性组织中 TGF-β1、VEGF 和 IL-10 的表达水平,并与相应的交界性、良性和无肿瘤组织进行比较。此外,通过 Pearson 秩相关分析和多因素 Logistic 回归分析,研究了这些细胞因子水平之间的关系以及表达与 EOC 预后的相关性。通过体外实验研究了 TGF-β1、VEGF 和 IL-10 在卵巢癌免疫抑制微环境中的作用,包括树突状细胞(DC)成熟和 CD4+CD25+FoxP3+Treg 的产生。

结果

TGF-β1、VEGF 和 IL-10 在 100%、74.69%和 54.96%的 EOC 患者中表达。TGF-β1 是 EOC 的独立预后因素。IL-10 与 VEGF 显著共表达。体外实验中,VEGF 和 TGF-β1 强烈干扰 DC 成熟,导致不成熟的 DC 分泌高水平的 IL-10,在肿瘤部位周围积累。TGF-β1 和 IL-10 诱导 Treg 产生,而无需 DC 进行抗原呈递。

结论

TGF-β1、VEGF 和 IL-10 在 EOC 中发挥重要作用,并可导致频繁的免疫逃逸事件。

相似文献

1
Overexpression and immunosuppressive functions of transforming growth factor 1, vascular endothelial growth factor and interleukin-10 in epithelial ovarian cancer.上皮性卵巢癌中转化生长因子 1、血管内皮生长因子和白细胞介素 10 的过表达及其免疫抑制功能。
Chin J Cancer Res. 2012 Jun;24(2):130-7. doi: 10.1007/s11670-012-0130-y.
2
Targeting cytokines secreted by CD4 CD25 CD127  regulatory T cells inhibits ovarian cancer progression.靶向 CD4 CD25 CD127 调节性 T 细胞分泌的细胞因子可抑制卵巢癌进展。
Scand J Immunol. 2019 Feb;89(2):e12736. doi: 10.1111/sji.12736. Epub 2018 Dec 27.
3
Title Prognosis Significance of ZEB2 and TGF-β1 as well as Other Clinical Characteristics in Epithelial Ovarian Cancer.标题:ZEB2 和 TGF-β1 及其他临床特征在卵巢上皮性癌中的预后意义。
Int J Gynecol Cancer. 2017 Sep;27(7):1343-1349. doi: 10.1097/IGC.0000000000001037.
4
Artesunate down-regulates immunosuppression from colorectal cancer Colon26 and RKO cells in vitro by decreasing transforming growth factor β1 and interleukin-10.青蒿琥酯通过降低转化生长因子β1和白细胞介素-10,在体外下调结肠直肠癌Colon26和RKO细胞的免疫抑制作用。
Int Immunopharmacol. 2015 Jul;27(1):110-21. doi: 10.1016/j.intimp.2015.05.004. Epub 2015 May 12.
5
BRAF mutant colorectal cancer cells mediate local immunosuppressive microenvironment through exosomal long noncoding RNAs.BRAF 突变型结肠癌细胞通过外泌体长链非编码 RNA 介导局部免疫抑制微环境。
World J Gastrointest Oncol. 2021 Dec 15;13(12):2129-2148. doi: 10.4251/wjgo.v13.i12.2129.
6
A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.分泌白细胞介素-10和转化生长因子-β1的CD4+CD25高表达Foxp3+ T细胞的一个独特亚群介导肿瘤微环境中的抑制作用。
Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4345-54. doi: 10.1158/1078-0432.CCR-07-0472.
7
Sub-optimal primary surgery leads to unfavorable immunological changes in ovarian cancer patients.原发性手术效果欠佳会导致卵巢癌患者出现不良免疫变化。
Immunobiology. 2018 Jan;223(1):1-7. doi: 10.1016/j.imbio.2017.10.021. Epub 2017 Oct 5.
8
Overexpression and interactions of interleukin-10, transforming growth factor beta, and vascular endothelial growth factor in esophageal squamous cell carcinoma.白细胞介素-10、转化生长因子β和血管内皮生长因子在食管鳞状细胞癌中的过表达及相互作用
World J Surg. 2009 Jul;33(7):1439-45. doi: 10.1007/s00268-009-0070-y.
9
Synergistic effect of regulatory T cells and proinflammatory cytokines in angiogenesis in the endometriotic milieu.调节性T细胞与促炎细胞因子在子宫内膜异位症环境中血管生成中的协同作用。
Hum Reprod. 2017 Jun 1;32(6):1304-1317. doi: 10.1093/humrep/dex067.
10
Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGF-β1 and upregulate expression of regulatory molecules on T cells: do they protect breast cancer cells from the immune response?从乳腺癌组织中分离出的脂肪来源干细胞 (ASCs) 表达 IL-4、IL-10 和 TGF-β1,并上调 T 细胞上的调节分子表达:它们是否能保护乳腺癌细胞免受免疫反应的影响?
Cell Immunol. 2011;266(2):116-22. doi: 10.1016/j.cellimm.2010.09.005. Epub 2010 Sep 27.

引用本文的文献

1
Dendritic cells: understanding ontogeny, subsets, functions, and their clinical applications.树突状细胞:了解其个体发育、亚群、功能及其临床应用。
Mol Biomed. 2025 Sep 8;6(1):62. doi: 10.1186/s43556-025-00300-8.
2
Advancing Breast Cancer Treatment: The Role of Immunotherapy and Cancer Vaccines in Overcoming Therapeutic Challenges.推进乳腺癌治疗:免疫疗法和癌症疫苗在克服治疗挑战中的作用。
Vaccines (Basel). 2025 Mar 24;13(4):344. doi: 10.3390/vaccines13040344.
3
Efficacy and safety of low-dose cyclophosphamide combined with lenvatinib, pembrolizumab and TACE for unresectable hepatocellular carcinoma: A single-center, prospective, single-arm clinical trial.低剂量环磷酰胺联合乐伐替尼、帕博利珠单抗及经动脉化疗栓塞术治疗不可切除肝细胞癌的疗效与安全性:一项单中心、前瞻性、单臂临床试验
Chin J Cancer Res. 2024 Apr 30;36(2):114-123. doi: 10.21147/j.issn.1000-9604.2024.02.02.
4
The complex role of IL-10 in malignant ascites: a review.IL-10 在恶性腹水的复杂作用:综述。
Cancer Immunol Immunother. 2024 Jan 27;73(2):32. doi: 10.1007/s00262-023-03616-y.
5
Cytokines as Prognostic Biomarkers of Epithelial Ovarian Cancer (EOC): A Systematic Review and Meta-Analysis.细胞因子作为上皮性卵巢癌(EOC)的预后生物标志物:一项系统评价和荟萃分析
Asian Pac J Cancer Prev. 2021 Feb 1;22(2):315-323. doi: 10.31557/APJCP.2021.22.2.315.
6
IL-10 Signaling in the Tumor Microenvironment of Ovarian Cancer.卵巢癌肿瘤微环境中的 IL-10 信号传导。
Adv Exp Med Biol. 2021;1290:51-65. doi: 10.1007/978-3-030-55617-4_3.
7
Tumor and Systemic Immunomodulatory Effects of MEK Inhibition.MEK 抑制的肿瘤和全身免疫调节作用。
Curr Oncol Rep. 2021 Feb 6;23(2):23. doi: 10.1007/s11912-020-01008-4.
8
Single nucleotide polymorphism of transforming growth factor-β1 and interleukin-6 as risk factors for ovarian cancer.转化生长因子-β1和白细胞介素-6的单核苷酸多态性作为卵巢癌的危险因素
Cent Eur J Immunol. 2020;45(3):267-275. doi: 10.5114/ceji.2020.101242. Epub 2020 Nov 1.
9
Rapid Affinity Maturation of Novel Anti-PD-L1 Antibodies by a Fast Drop of the Antigen Concentration and FACS Selection of Yeast Libraries.通过快速降低抗原浓度和使用流式细胞术筛选酵母文库,快速获得新型抗 PD-L1 抗体的亲和力成熟。
Biomed Res Int. 2019 Dec 28;2019:6051870. doi: 10.1155/2019/6051870. eCollection 2019.
10
Skin Allografting Activates Anti-tumor Immunity and Suppresses Growth of Colon Cancer in Mice.皮肤同种异体移植激活小鼠抗肿瘤免疫并抑制结肠癌生长。
Transl Oncol. 2018 Aug;11(4):890-899. doi: 10.1016/j.tranon.2018.04.012. Epub 2018 May 21.

本文引用的文献

1
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.
2
Induction of monocyte chemoattractant protein-1 and interleukin-10 by TGFbeta1 in melanoma enhances tumor infiltration and immunosuppression.TGFβ1 诱导黑色素瘤中单核细胞趋化蛋白-1 和白细胞介素-10 的表达,增强肿瘤浸润和免疫抑制。
Cancer Res. 2011 Feb 1;71(3):812-21. doi: 10.1158/0008-5472.CAN-10-2698. Epub 2010 Dec 15.
3
Clinicopathological significance of p53, hypoxia-inducible factor 1alpha, and vascular endothelial growth factor expression in colorectal cancer.结直肠癌中 p53、缺氧诱导因子 1α 和血管内皮生长因子表达的临床病理意义。
Anticancer Res. 2010 Oct;30(10):4163-8.
4
Expression of IL-10 in human normal and cancerous ovarian tissues and cells.白细胞介素-10 在人正常和癌变卵巢组织和细胞中的表达。
Eur Cytokine Netw. 2010 Jun;21(2):122-8. doi: 10.1684/ecn.2010.0188. Epub 2010 Apr 30.
5
Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia.基质调节性T细胞与贲门胃癌的良好预后相关。
BMC Gastroenterol. 2009 Sep 4;9:65. doi: 10.1186/1471-230X-9-65.
6
Expression of CD4(+)CD25(high)CD127(low/-) regulatory T cells in transitional cell carcinoma patients and its significance.CD4(+)CD25(high)CD127(low/-)调节性T细胞在移行细胞癌患者中的表达及其意义。
J Clin Lab Anal. 2009;23(4):197-201. doi: 10.1002/jcla.20331.
7
Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients.肿瘤内调节性T细胞增多与肝细胞癌患者的肿瘤内巨噬细胞及预后不良相关。
Int J Cancer. 2009 Oct 1;125(7):1640-8. doi: 10.1002/ijc.24556.
8
The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC.非小细胞肺癌患者外周血中FOXP3 + 调节性T细胞的患病率。
Cancer Biother Radiopharm. 2009 Jun;24(3):357-67. doi: 10.1089/cbr.2008.0612.
9
A high proportion of bone marrow T cells with regulatory phenotype (CD4+CD25hiFoxP3+) in Ewing sarcoma patients is associated with metastatic disease.尤因肉瘤患者中具有调节性表型(CD4+CD25hiFoxP3+)的骨髓T细胞比例较高与转移性疾病相关。
Int J Cancer. 2009 Aug 15;125(4):879-86. doi: 10.1002/ijc.24461.
10
Overexpression and interactions of interleukin-10, transforming growth factor beta, and vascular endothelial growth factor in esophageal squamous cell carcinoma.白细胞介素-10、转化生长因子β和血管内皮生长因子在食管鳞状细胞癌中的过表达及相互作用
World J Surg. 2009 Jul;33(7):1439-45. doi: 10.1007/s00268-009-0070-y.